| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Rafael Bañares | Q39185679 |
| Luis-Miguel Molinero | Q77706623 | ||
| P2093 | author name string | Javier Zamora | |
| Agustín Albillos | |||
| Judith Gomez-Camarero | |||
| Rosario Gonzalez | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | 109-122 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis | |
| P478 | volume | 149 |
| Q43787030 | 6 years of the International Union of Societies of Immunology. Presidential report (Brighton 1974) |
| Q34781853 | A systematic review and meta-analysis of randomized trials and prospective studies comparing covered and bare self-expandable metal stents for the treatment of malignant obstruction in the digestive tract |
| Q54959782 | Adherence to surveillance endoscopy following hospitalization for index esophageal variceal hemorrhage. |
| Q35207776 | Application of endoscopy in improving survival of cirrhotic patients with acute variceal hemorrhage |
| Q43605312 | Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries? |
| Q94334996 | Banding ligation versus no intervention for primary prevention in adults with oesophageal varices |
| Q34428788 | Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis. |
| Q27012922 | Beta-blockers in liver cirrhosis |
| Q47194571 | Can Non-Selective Beta-Blockers (NSBBs) Prevent Enlargement of Small Esophageal Varices in Patients with Cirrhosis? A Meta-analysis |
| Q34399357 | Clinical Pharmacology of Portal Hypertension |
| Q41341656 | Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials |
| Q94453272 | Comparison of the effectiveness of 11 mainstay treatments for secondary prophylaxis of variceal bleeding in patients with cirrhosis: A network meta-analysis |
| Q38424360 | Complications of cirrhosis. A 50 years flashback. |
| Q38168180 | Drug therapies in liver disease. |
| Q38027840 | Endoscopic management of esophageal varices |
| Q38261692 | Endoscopic management of esophagogastric varices in Japan |
| Q39580239 | Endoscopic management of portal hypertension |
| Q94335368 | Endoscopic therapy and beta‐blockers for secondary prevention in adults with cirrhosis and oesophageal varices |
| Q89844911 | Endoscopic treatments for portal hypertension |
| Q52775590 | Favorable Effects of Endoscopic Ligation Combined with Drugs on Rebleeding and Mortality in Cirrhotic Patients: A Network Meta-Analysis. |
| Q43201682 | Gastrointestinal bleeding: Secondary prophylaxis for variceal bleeding |
| Q92522263 | KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications |
| Q87200165 | Liver cirrhosis |
| Q37489472 | Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program |
| Q36478606 | Management by the intensivist of gastrointestinal bleeding in adults and children |
| Q54836960 | Management of Variceal Hemorrhage. |
| Q43861512 | Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices |
| Q34623430 | Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices. |
| Q48122792 | Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites. |
| Q38772074 | Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function |
| Q26769730 | PROPOSAL OF A CLINICAL CARE PATHWAY FOR THE MANAGEMENT OF ACUTE UPPER GASTROINTESTINAL BLEEDING |
| Q37355613 | Pathogenesis and management of alcoholic liver cirrhosis: a review. |
| Q37811073 | Portal hypertension: Diagnosis and management with particular reference to variceal hemorrhage |
| Q38250393 | Portal hypertension: pathophysiology, diagnosis and management |
| Q49717262 | Prevention and management of gastroesophageal varices. |
| Q85041634 | Prevention of esophageal variceal bleeding |
| Q42737064 | Retrospective studies with inconsistent data: results, conclusions and recommendations should be taken with a grain of salt |
| Q57176085 | Role of band ligation for secondary prophylaxis of variceal bleeding |
| Q28291828 | Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis |
| Q38764257 | Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis |
| Q57170856 | Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis |
| Q24188170 | Surgical portosystemic shunts versus devascularisation procedures for variceal bleeding due to hepatosplenic schistosomiasis |
| Q24187528 | Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage |
| Q37532659 | Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from oesophageal varices |
| Q21092360 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration |
| Q27860581 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration |
| Q37777477 | The Role of Endoscopy in Secondary Prophylaxis of Esophageal Varices |
| Q37229874 | The secondary prophylactic efficacy of beta-blocker after endoscopic gastric variceal obturation for first acute episode of gastric variceal bleeding |
| Q34265176 | Treatment of portal hypertension |
| Q36374829 | U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. |
| Q92005729 | Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence |
| Q34996003 | Variceal band ligation in the prevention of variceal bleeding: a multicenter trial |
| Q37313406 | Variceal bleeding : pharmacological treatment and prophylactic strategies |
| Q39190393 | Variceal bleeding in cirrhotic patients |
| Q34622605 | Variceal bleeding: consensus meeting report from the Brazilian Society of Hepatology. |
| Q87945859 | [Frontal brain volume reduction due to antipsychotic drugs?] |
Search more.